Guardian Pharmacy Earnings Estimate
| GRDN Stock | 33.43 0.03 0.09% |
Guardian Pharmacy Earnings Estimation Breakdown
The calculation of Guardian Pharmacy's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Guardian Pharmacy is estimated to be 0.245625 with the future projection ranging from a low of 0.24 to a high of 0.2525. Please be aware that this consensus of annual earnings estimates for Guardian Pharmacy Services is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.24 Lowest | Expected EPS | 0.25 Highest |
Guardian Pharmacy Earnings Projection Consensus
Suppose the current estimates of Guardian Pharmacy's value are higher than the current market price of the Guardian Pharmacy stock. In this case, investors may conclude that Guardian Pharmacy is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Guardian Pharmacy's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 0.0% | 0.25 | 0.245625 | 0.68 |
Guardian Pharmacy Earnings History
Earnings estimate consensus by Guardian Pharmacy analysts from Wall Street is used by the market to judge Guardian Pharmacy's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Guardian Pharmacy's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Guardian Pharmacy Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy Earnings per Share Projection vs Actual
Actual Earning per Share of Guardian Pharmacy refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Guardian Pharmacy Services predict the company's earnings will be in the future. The higher the earnings per share of Guardian Pharmacy, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Guardian Pharmacy Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Guardian Pharmacy, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Guardian Pharmacy should always be considered in relation to other companies to make a more educated investment decision.Guardian Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Guardian Pharmacy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-10 | 2025-09-30 | 0.235 | 0.25 | 0.015 | 6 | ||
2025-08-11 | 2025-06-30 | 0.215 | 0.23 | 0.015 | 6 | ||
2025-04-01 | 2025-03-31 | 0.22 | 0.19 | -0.03 | 13 | ||
2025-03-27 | 2024-12-31 | 0.22 | 0.2381 | 0.0181 | 8 | ||
2024-11-12 | 2024-09-30 | 0.19 | -2.0 | -2.19 | 1152 | ||
2024-08-28 | 2024-06-30 | 0 | 0.245 | 0.245 | 0 |
About Guardian Pharmacy Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Guardian Pharmacy earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Guardian Pharmacy estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Guardian Pharmacy fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 15.4 M | 13.7 M | |
| Earnings Yield | (0.08) | (0.08) | |
| Price Earnings Ratio | (16.55) | (15.72) | |
| Price Earnings To Growth Ratio | 0.02 | 0.02 |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.62 | 3GX | HF FOODS GRP | PairCorr |
| 0.42 | P5F | Performance Food | PairCorr |
| 0.42 | MRU | Metro Inc | PairCorr |
| 0.39 | HITI | High Tide | PairCorr |
| 0.33 | GO | Grocery Outlet Holding | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.